Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization.

By A. Castano, T. Demidova, Michael R Hamblin. Photodiagnosis and Photodynamic Therapy, 2004

1,750 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Materials Chemistry, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/89257633a2639ab46e52af004f2c48b9b796672b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

1. Michael R Hamblin
2. David B. Graves

In Pulmonary and Respiratory Medicine

1. Michael R Hamblin
2. David B. Graves

Citations in the corpus

• Oncologic photodynamic therapy photosensitizers: a clinical review. (2010, background): “[18] Castano AP, Demidova TN, Hamblin MR.”
• Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions (2017, background): “Depending on its characteristics (see later in this review) a PS will generally localize towards organelles such as the plasma membrane, lysosomes, mitochondria, Golgi apparatus or endoplasmic reticulum (ER) [21].”
• Photophysics and photochemistry of photodynamic therapy: fundamental aspects (2009, background): “The absorption spectra of these molecules define the optical window for PDT in tissue (Fig. 2, [ 9 , 11, 13]).”
• Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. (2005, background): “This question is closely related to the intracellular localization of the PS that was covered in Part I [9].”